Gastroenterology and Hepatology
The TRI has a strong research program into gastrointestinal and liver disease in collaboration with clinicians at the Princess Alexandra Hospital and other partners such as the Mater Medical Research Institute/Mater Hospital.
This research program brings together researchers, scientists and clinicians to better understand the pathophysiology of a range of gastrointestinal and liver diseases aiming to prevent or more effectively treat highly prevalent disorders of the digestive tract.
Find out more about these research programs below, which are being undertaken in collaboration with associated investigators from the Princess Alexandra Hospital and other partners such as the Mater Medical Research Institute/Mater Hospital.
| Resources | |
|
Use of the sheathed (Brisbane Aseptic Biopsy Device) or standard biopsy devices to obtain gastrointestinal biopsies to characterise mucosal bacterial colonisation |
Click here to view |
|
Nutrient challenge test |
Click here to view |
|
Intestinal permeability test |
Click here to view |
|
Measuring bacterial density on biopsy samples using qPCR |
Click here to view |
|
Hydrogen breath test for small intestinal bacterial overgrowth (SIBO) using glucose |
Click here to view |
|
Liver function breath test 13C with methacetin |
Click here to view |
|
Pancreatic function breath test 13C with mixed triglyceride |
Click here to view |
|
Helicobacter pylori 13C urea breath test |
Click here to view |
|
Gastric Emptying 13C Breath Test (Substrate: 13C Octanoic Acid for Solid GE) |
|
|
DNA extraction from mucosal tissue |
|
|
Illumina Sequencing Library Prep |
|
